Zydus Lifesciences Stock Performance
as on August 21, 2026 at 9:31 pm IST
Day's Low
₹1,099.40₹1,120.00
1.84%
Downside
52 Week's Low
52 Week's High
₹835.50₹1,205.00
25.40%
Downside
7.59%
Upside

Zydus Lifesciences share price movements today
- Previous Close
- ₹1,107.70
- Open
- ₹1,109.60
- Volume
- 10.06L
- Upper Circuit
- ₹1,148.60
- Lower Circuit
- ₹1,081.80
- Day's Low - High
- ₹1,099.40 - ₹1,120.00
- 52 Week Low - High
- ₹835.50 - ₹1,205.00
Zydus Lifesciences Historical Returns
- 1 Month Return
- -0.56 %
- 3 Month Return
- + 7.8 %
- 1 Year Return
- + 13.27 %
- 3 Year Return
- + 72.07 %
- 5 Year Return
- + 104.72 %
Zydus Lifesciences Fundamentals
as on August 21, 2026 at 4:01 pm IST
Market Cap
₹1,11,720.43 Cr
Return on Equity (ROE)
15.87
PE Ratio (TTM)
0Return on capital employed (ROCE)
15.9
Industry PE ratio
-
Beta (LTM)
0.7
P/B Ratio
3.7
Dividend Yield
0.11
PEG Ratio
0Quarterly Earnings Growth YOY
-35.93
EPS (TTM)
49.96
Book Value
269.5
Zydus Lifesciences Technical Analysis
Track how Zydus Lifesciences technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | -1.21 | |
CCI (20) | -53.1 | Neutral |
RSI (14) | 40.97 | Neutral |
Momentum (10) | -9.7 | |
ADI (14) | 54.52 | |
Ultimate Oscillator (7,14,28) | 7.51 |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 1112.71 | |
EMA (20) | 1112.06 | |
VWMA (20) | 1111.58 | |
SMA (50) | 1114.24 | |
EMA (50) | 1112.48 | |
SMA (200) | 1105.7 | Bullish |
EMA (200) | 1108.32 | Bullish |
KAMA (200) | 1114.76 | |
DEMA (200) | 1110.57 |
Zydus Lifesciences Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Zydus Lifesciences with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 1,10,493.50 | 20.49% | 0.69 | 5,026 | 51,180 | |
| BUY | 7,648.26 | -12.46% | 0.00 | 413 | 2,013 | |
| BUY | 93,392.90 | 27.09% | 0.60 | 3,502 | 33,653 | |
| BUY | 55,505.00 | 7.57% | 0.00 | 1,414 | 6,445 | |
| BUY | 50,816.73 | 19.09% | 0.56 | 1,035 | 3,821 |
Market expectation of Zydus Lifesciences Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
53.33%
Buy
23.33%
Hold
23.33%
Sell
Zydus Lifesciences Stock’s Investor Sentiment and Interest
Investment in Zydus Lifesciences Ltd Shares on INDmoney has grown by 8.81% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:8.81% versus previous 30 day period
Search interest for Zydus Lifesciences Ltd Stock has increased by 4% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:4% versus previous 30 day period
Zydus Lifesciences Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Zydus Lifesciences Ltd Annual Profit & Loss
Figures in Rupees Crores
Zydus Lifesciences Ltd Cash Flow
Figures in Rupees Crores
Zydus Lifesciences Corporate Actions
View detailed summary of the earnings and dividend history of Zydus Lifesciences.
Zydus Lifesciences Ltd Earnings Results
Zydus Lifesciences Ltd’s net profit fell -35.93% since last year same period to ₹939.80Cr in the Q1 2026-2027. On a quarterly growth basis, Zydus Lifesciences Ltd has generated -26.15% fall in its net profits since last 3-months.
Read More about Earnings ResultsZydus Lifesciences Ltd Dividends May,2026
In the quarter ending March 2026, Zydus Lifesciences Ltd has declared dividend of ₹1.00 per share on 19 May 2026 - translating a dividend yield of 0.09%.
Read More about Dividends
Indices Featuring Zydus Lifesciences Stock
Check stock indices that include Zydus Lifesciences.
Insights on Zydus Lifesciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPromoter Holding Up

Promoters have increased holdings from 75.00% to 75.01% in Jun 2026 quarter
POSITIVE IMPACTMF Holding Up

Mutual Funds have increased holdings from 4.88% to 5.12% in Jun 2026 quarter
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 4 quarters, 6.23K Cr → 8.12K Cr (in ₹), with an average increase of 8.4% per quarter
NO EFFECTAgainst Peers

In the last 3 years, Torrent Pharmaceuticals Ltd has given 153.3% return, outperforming this stock by 83.7%
NO EFFECTAgainst Peers

In the last 1 year, Divis Laboratories Ltd has given 42.2% return, outperforming this stock by 29.8%
NEGATIVE IMPACTRetail Holding Down

Retail Investor have decreased holdings from 6.86% to 6.83% in Jun 2026 quarter
NEGATIVE IMPACTPrice Dip

In the last 7 days, ZYDUSLIFE stock has moved down by -2.4%
NEGATIVE IMPACTFII Holding Down

Foreign Institutions have decreased holdings from 6.95% to 6.88% in Jun 2026 quarter
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 2 quarters, 1.27K Cr → 939.8 Cr (in ₹), with an average decrease of 26.2% per quarter
Zydus Lifesciences Stock Futures & Options Contracts
View the latest movement in Zydus Lifesciences Futures & Options, including strike prices, expiry dates, and percentage changes.
Zydus Lifesciences Options
Zydus Lifesciences Futures
About Zydus Lifesciences Ltd
The company has a strong presence in the global market and is known for its high-quality pharmaceutical products. It manufactures a wide range of generic and specialty drugs, including cardiovascular, anti-infective, anti-diabetic, and oncology medicines. Zydus also produces over-the-counter products and nutritional supplements. Some of its top products include Zetia, Atorvastatin, and Metformin.
Zydus Lifesciences Ltd is also known for its popular brands, such as Cadila, Nutralite, and Zydus Wellness. The company has a strong presence in the Indian market, with its products being sold in more than 20,000 stores across the country. It also exports its products to over 100 countries worldwide.
Revenue: ₹7,802.00Cr as on June 2026 (Q1 FY27)
Net Profit: ₹952.40Cr as on June 2026 (Q1 FY27)
Listing date: 18 Apr, 2000
Chairperson Name: Pankaj R Patel
| Organisation | Zydus Lifesciences Ltd |
| Headquarters | Ahmedabad |
| Industry | Pharmaceuticals |
| CEO | Pankaj R Patel |
| E-voting on shares | Click here to vote |
FAQs
What is Zydus Lifesciences share price today?
Zydus Lifesciences share price today stands at ₹1120 as on at the close of the market. Zydus Lifesciences share today touched a day high of ₹1120 and a low of ₹1099.4.
What is the 52 week high and 52 week low range for Zydus Lifesciences share?
Zydus Lifesciences touched a 52 week high of ₹1205 and a 52 week low of ₹835.5. Zydus Lifesciences share price today i.e. is closed at ₹1120, which is -7.05% down from its 52 week high and 34.05% up from its 52 week low.
What is Zydus Lifesciences's market capitalisation today?
Zydus Lifesciences market capitalisation is ₹1,11,720.43 Cr as on .
How to buy Zydus Lifesciences shares?
To buy Zydus Lifesciences shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for ZYDUSLIFE or Zydus Lifesciences Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Zydus Lifesciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Zydus Lifesciences trading volume today?
Zydus Lifesciences trading volume is 10.06L as on . This means that 10.06L shares of Zydus Lifesciences were bought and sold on the stock market during today's trading session.